Neogenomics (NEO) Cash & Equivalents Growth (1y) (2011 - 2026)
Neogenomics (NEO) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | -11.19% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 47.04% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 19.65% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 21.60% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -6.38% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 12.96% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 11.35% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -16.86% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 96.24% |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn | -5.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.94% |
| Mar 31, 2026 | -57.79% |
| Dec 31, 2025 | -56.51% |
| Sep 30, 2025 | -54.66% |
| Jun 30, 2025 | -56.43% |
| Mar 31, 2025 | 4.30% |
| Dec 31, 2024 | 7.16% |
| Sep 30, 2024 | 18.21% |
| Jun 30, 2024 | 22.84% |
| Mar 31, 2024 | 20.43% |
| Dec 31, 2023 | 30.13% |
| Sep 30, 2023 | 15.07% |
| Jun 30, 2023 | 1.92% |
| Mar 31, 2023 | -9.90% |
| Dec 31, 2022 | -16.93% |
| Sep 30, 2022 | -21.86% |
| Jun 30, 2022 | -23.09% |
| Mar 31, 2022 | -50.01% |
| Dec 31, 2021 | 38.53% |
| Sep 30, 2021 | 46.02% |